Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-29 @ 4:15 PM
Study NCT ID:
NCT00663806
Status:
COMPLETED
Last Update Posted:
2014-12-02
First Post:
2008-04-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IV Study of Cipro XR in Uncomplicated UTI
Sponsor:
Bayer
Organization:
Study Overview
Official Title:
EXPRESS: Evaluating Cipro XR Patient Response, Education, Safety, and Satisfaction
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EXPRESS
Brief Summary:
Safety and efficacy of Cipro XR in a naturalistic setting and the effectiveness of an educational brochure. - Women with urinary tract infections were treated with Cipro XR. They were also given a brochure with information about urinary tract infections and later tested on the information.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: